Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.2M Sell
311,229
-4,729
-1% -$432K 2.67% 17
2026
Q1
$32.4M Buy
315,958
+2,134
+0.7% +$241K 3.14% 16
2025
Q4
$39.3M Buy
313,824
+266
+0.1% +$33.9K 3.35% 14
2025
Q3
$42M Sell
313,558
-38,149
-11% -$5.01M 3.18% 14
2025
Q2
$46.8M Buy
351,707
+10,921
+3% +$1.44M 4% 12
2025
Q1
$45.2M Buy
340,786
+25,353
+8% +$3.23M 4.33% 13
2024
Q4
$35.7M Buy
315,433
+16,300
+5% +$1.88M 3.36% 17
2024
Q3
$34.1M Buy
299,133
+3,977
+1% +$436K 3.63% 15
2024
Q2
$30.7M Buy
+295,156
New +$31.3M 3.65% 15
2024
Q1
Sell
-211,927
Closed -$24M 38
2023
Q4
$24M Buy
+211,927
New +$21.2M 4.37% 12

Other funds holding ABT

J. Stern & Co's ABT Position: Q2 2026 in Review

J. Stern & Co reduced its Abbott (ABT) stake by 1.5% in Q2 2026, selling an estimated $432K and leaving 311,229 shares worth $28.2M. The position accounts for 2.67% of the portfolio, ranked #17.

J. Stern & Co first reported a position in ABT in Q4 2023 and has held it in 10 quarters since. The position peaked at $46.8M in Q2 2025. 2,975 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • J. Stern & Co held 311,229 shares of Abbott worth $28.2M as of Q2 2026.
  • J. Stern & Co sold 4,729 Abbott shares in Q2 2026, an estimated $432K.
  • Abbott made up 2.67% of J. Stern & Co's portfolio in Q2 2026, its #17 holding.
  • J. Stern & Co first reported a position in Abbott in Q4 2023 and has held it in 10 quarters since.
  • J. Stern & Co's Abbott position peaked at $46.8M in Q2 2025.
  • 2,975 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on J. Stern & Co's 13F filing for Q2 2026, filed 14 Aug 2026.